EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Outcomes After Aspirin Discontinuation Among Baseline Users in Contemporary Primary Prevention Aspirin Trials: A Meta-Analysis

Ruth Campbell, Mark R Nelson iD, John J McNeill iD, John W McEvoy iD

Circulation · 27.02.2024 · 149 (9) · 722-724

DOI: 10.1161/circulationaha.123.065420 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Circulation, erschienen am 27.02.2024. Verfasst von Ruth Campbell und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Prevention and Cardiovascular Health and School of Medicine, University of Galway, Ireland (R.C., J.W.M.E.). Hauptthemen laut MEDLINE: Aspirin, Cardiovascular Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on available evidence, including the results of 3 trials published in 2018 (ASPREE, ASCEND, and ARRIVE) [1][2][3] , guidelines no longer recommend low-dose aspirin for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in most adults.Indeed, US guidelines now advise against the use of aspirin for primary prevention among adults aged over 70 years.However, the majority of participants in these 3 trials were not previously taking aspirin.Therefore, these trials predominantly tested the effect on ASCVD outcomes of randomization to initiate aspirin vs. placebo among aspirin naïve adults.This raises a key clinical question, should aspirin be discontinued in persons already being treated with it?Compared with continuing aspirin, results from observational studies suggest a 28% higher ASCVD risk among adults characterized as primary prevention who discontinue aspirin in the absence of a clear indication.4 Determining whether this observed higher risk after aspirin discontinuation is causal or simply associated with confounding requires randomized data.Among the 47,140 participants in the 3 randomized trials published in 2018 assessing lowdose aspirin versus placebo for primary ASCVD risk prevention, approximately 15% (7,222) were regularly taking aspirin prior to enrolment (the ARRIVE trial excluded persons taking aspirin at trial screening 2 ).These 7,222 participants provide an opportunity for exploratory analyses to evaluate outcomes based on randomization to continue or stop aspirin among baseline users.In a previously published subgroup analysis, the ASPREE trial authors studied 1,714 participants who were taking aspirin at least twice weekly before enrolment.Those randomized to stop aspirin and take placebo had a trend to increased risk for ASCVD

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinCardiovascular DiseasesHumansRisk FactorsResearch DesignPrimary PreventionPlatelet Aggregation Inhibitors

Stichwörter der Autor:innen

aspirincardiovascular diseasesprimary prevention

Substanzen

AspirinPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • National Institute for Prevention and Cardiovascular Health and School of Medicine, University of Galway, Ireland (R.C., J.W.M.E.).
  • Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (M.R.N.).
  • Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia (M.R.N., J.J.M.N.).

ORCID-Profile: Mark R Nelson, John J McNeill, John W McEvoy

Förderung

  • NIA NIH HHS

Zitieren

APA

Campbell, R., Nelson, M. R., McNeill, J. J., & McEvoy, J. W. (2024). Outcomes After Aspirin Discontinuation Among Baseline Users in Contemporary Primary Prevention Aspirin Trials: A Meta-Analysis. Circulation, 149(9), 722-724. https://doi.org/10.1161/circulationaha.123.065420

Vancouver

Campbell R, Nelson MR, McNeill JJ, McEvoy JW. Outcomes After Aspirin Discontinuation Among Baseline Users in Contemporary Primary Prevention Aspirin Trials: A Meta-Analysis. Circulation. 2024;149(9):722-724. doi:10.1161/circulationaha.123.065420

BibTeX
@article{Campbell2024,
  author = {Campbell, Ruth and Nelson, Mark R and McNeill, John J and McEvoy, John W},
  title = {Outcomes After Aspirin Discontinuation Among Baseline Users in Contemporary Primary Prevention Aspirin Trials: A Meta-Analysis},
  journal = {Circulation},
  year = {2024},
  volume = {149},
  number = {9},
  pages = {722--724},
  doi = {10.1161/circulationaha.123.065420}
}
Kostenlos starten →